Few blood test results trigger as much anxiety as seeing CA-125 flagged above the reference range. The name itself — Cancer Antigen 125 — sounds alarming. But before you spiral into worst-case scenarios, know this: the vast majority of CA-125 elevations are not caused by cancer.
This guide explains what CA-125 actually measures, what normal levels look like across different populations, the many non-cancerous reasons it may be elevated, and when further investigation is truly warranted.
Disclaimer: This information is for educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.
What Is CA-125?
CA-125 (Cancer Antigen 125) is a glycoprotein produced by cells lining the peritoneum (abdominal cavity), pleura, pericardium, and the epithelial surface of the ovaries, fallopian tubes, and endometrium. It was first identified in 1981 by Dr. Robert Bast at Harvard and rapidly became the most widely used biomarker in gynecologic oncology.
In healthy individuals, small amounts of CA-125 are present in the bloodstream. When tissues become inflamed, irritated, or malignant, CA-125 production increases and spills into the blood in measurable quantities. This is why elevated levels can signal many different conditions — not just cancer.
When Is a CA-125 Test Ordered?
Physicians typically order CA-125 in these clinical scenarios:
- Evaluating a pelvic mass — When imaging (ultrasound, CT, or MRI) reveals an ovarian cyst or mass, CA-125 helps stratify malignancy risk
- Monitoring ovarian cancer treatment — Serial CA-125 measurements track response to chemotherapy and detect recurrence
- High-risk screening — Women with BRCA1/BRCA2 mutations or strong family histories of ovarian or breast cancer
- Evaluating endometriosis — CA-125 is moderately elevated in advanced endometriosis and can track treatment response
- Differential diagnosis — Distinguishing between benign and potentially malignant conditions in the pelvis
CA-125 is not recommended as a routine screening test for average-risk women. Both the American College of Obstetricians and Gynecologists (ACOG) and the U.S. Preventive Services Task Force (USPSTF) advise against it because of the high rate of false positives.
Normal Ranges for CA-125
The standard reference range used by most laboratories (Quest Diagnostics, LabCorp, Synlab):
| Population |
Reference Range |
| Premenopausal women |
0 – 35 U/mL (kU/L) |
| Postmenopausal women |
0 – 35 U/mL (kU/L) |
| Men |
0 – 35 U/mL (kU/L) |
Important context:
- The 35 U/mL cutoff was established to optimize sensitivity for advanced ovarian cancer, not as a health/disease boundary
- Approximately 1% of healthy women have CA-125 above 35 U/mL without any pathology
- During menstruation, CA-125 can physiologically rise to 50–60 U/mL
- In the first trimester of pregnancy, levels up to 65 U/mL are considered normal
- Some laboratories use a lower cutoff of 21 U/mL for postmenopausal women (the ROMA algorithm)
Non-Cancerous Causes of Elevated CA-125
This is where CA-125 earns its reputation for false positives. The following benign conditions commonly elevate CA-125, sometimes significantly:
Gynecologic Conditions
- Endometriosis — Levels can reach 100–200 U/mL in severe disease (stage III-IV). CA-125 correlates roughly with disease extent
- Ovarian cysts — Simple and complex cysts, especially when large or ruptured
- Pelvic inflammatory disease (PID) — Infection-driven peritoneal irritation raises CA-125
- Uterine fibroids — Particularly large or degenerating fibroids
- Adenomyosis — Endometrial tissue within the uterine wall
- Ectopic pregnancy — Peritoneal irritation from bleeding
Non-Gynecologic Conditions
- Liver cirrhosis and hepatitis — Peritoneal involvement and ascites are powerful drivers
- Congestive heart failure — Pericardial and peritoneal fluid accumulation
- Kidney failure — Reduced clearance and serosal inflammation
- Pancreatitis — Peritoneal inflammation
- Tuberculosis — Especially peritoneal TB, where CA-125 can exceed 500 U/mL
- Any condition causing ascites or pleural effusion
The key takeaway: CA-125 responds to any irritation of serosal surfaces. It is organ-nonspecific and disease-nonspecific.
CA-125 and Ovarian Cancer
Despite its limitations, CA-125 remains the single most important blood marker for epithelial ovarian cancer, which accounts for roughly 90% of all ovarian malignancies.
Sensitivity by Stage
| Stage |
CA-125 > 35 U/mL |
Typical Levels |
| Stage I |
~50% |
35–65 U/mL |
| Stage II |
~70–80% |
65–200 U/mL |
| Stage III |
~90% |
200–500+ U/mL |
| Stage IV |
~95% |
500–10,000+ U/mL |
The low sensitivity in early-stage disease is a critical limitation — it means CA-125 alone cannot reliably detect ovarian cancer when it is most curable. This is precisely why it is not recommended for routine screening in average-risk populations.
The ROMA Algorithm
The Risk of Ovarian Malignancy Algorithm (ROMA) combines CA-125, HE4 (a newer biomarker), and menopausal status to calculate a probability score. ROMA improves specificity compared to CA-125 alone:
- HE4 is less likely to be elevated in endometriosis and benign ovarian cysts, making it a useful complement
- A high ROMA score (>7.4% premenopausal, >25.3% postmenopausal) suggests referral to a gynecologic oncologist
If your doctor ordered both CA-125 and HE4, your results are likely being evaluated using ROMA or a similar risk model.
Other Cancers That Elevate CA-125
While CA-125 is most strongly associated with ovarian cancer, it can also be elevated in:
- Endometrial cancer — Elevated in ~20–30% of cases
- Fallopian tube cancer
- Peritoneal carcinomatosis from any primary site
- Breast cancer — Especially metastatic
- Pancreatic and lung cancer — Typically when serosal surfaces are involved
How to Interpret Your Results
Mildly Elevated (35–65 U/mL)
In a premenopausal woman, this is most commonly caused by endometriosis, ovarian cysts, fibroids, or even normal menstrual cycle variation. The risk of ovarian cancer at this level in a premenopausal woman is very low (under 1%).
In a postmenopausal woman, even mild elevation warrants closer attention because the benign causes (menstruation, pregnancy, endometriosis) are no longer factors. However, liver disease, heart failure, and other conditions must still be excluded.
Moderately Elevated (65–200 U/mL)
Requires investigation regardless of menopausal status. Common causes include advanced endometriosis, large ovarian cysts, pelvic infection, liver disease, and — less commonly — malignancy. Imaging (transvaginal ultrasound) is typically the next step.
Significantly Elevated (>200 U/mL)
Levels above 200 U/mL raise significant concern for malignancy, especially in postmenopausal women or when imaging shows a complex pelvic mass. However, even at this level, non-cancerous conditions (peritoneal TB, severe cirrhosis, Meigs syndrome) can be responsible.
Serial Monitoring — Trend Matters More Than a Single Value
A single CA-125 measurement is a snapshot. The trend over time tells a much more meaningful story:
- Rising CA-125 on serial measurements is more concerning than a single elevated value
- Falling CA-125 during treatment is a positive prognostic sign
- Doubling time helps predict recurrence speed in monitored patients
Preparing for a CA-125 Blood Test
To ensure accurate results:
- Timing matters — Avoid testing during menstruation or within a few days after your period ends (premenopausal women)
- Fasting — Not strictly required, but fasting before blood tests is standard practice
- Report medications — Some treatments can influence results
- Avoid testing during acute illness — Infections and inflammation transiently elevate CA-125
For general tips on lab preparation, see our guide on how to prepare for a blood test.
When to See Your Doctor Immediately
Contact your healthcare provider promptly if:
- CA-125 is elevated and you have symptoms: persistent bloating, pelvic pain, difficulty eating, urinary urgency
- CA-125 is rising on serial measurements
- You are postmenopausal with any elevation above normal
- You have a family history of ovarian or breast cancer (especially BRCA1/BRCA2) and elevated CA-125
- Imaging reveals a complex ovarian mass alongside elevated CA-125
Remember that ovarian cancer symptoms are notoriously subtle. If your doctor ordered CA-125 based on your symptoms, follow through with all recommended evaluations regardless of the result.
CA-125 in Context: Related Tests
CA-125 is most useful when interpreted alongside other results. Consider reviewing:
Get Your Results Interpreted
If you have CA-125 results — or a full panel including HE4, CBC, and chemistry — and want a clear, personalized explanation, upload your results at Evallume for an instant AI-powered interpretation that considers your age, menopausal status, and clinical context.
This article is for informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Consult a healthcare professional for any medical concerns.
